STAMFORD, Conn., April 14, 2025 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA) (the “Company”), today announced that its Board of Directors (the “Board”) has approved a 1-for-3 reverse ...

Alis Biosciences has made a pitch to the hundreds of biotechs that are valued at less than the cash they have in the bank.

The reverse stock split was approved by Cara ... 1.5 million (prior to giving effect to the closing of the Merger). The reverse stock split will not change the authorized number of shares ...

the expected number of shares of common stock to be issued and outstanding following the reverse stock split and the Merger, and other statements regarding management’s intentions, plans ...

Elevation Oncology has become the second biotech this week to face calls from an activist investor to wind down the company.

Merger creates a Nasdaq-listed, clinical-stage biopharmaceutical company – Tvardi Therapeutics – developing novel treatments ...

Cara Therapeutics, Inc. (Nasdaq: CARA) (the "Company"), today announced that its Board of Directors (the "Board") has approved a 1-for-3 reverse stock ...

BML Capital Management, an activist investor that owns 9.9% of Elevation’s shares, is urging the company to wind down ...

The Edmonton Oilers’ playoff hopes took a huge hit after Darnell Nurse was handed a major penalty and game misconduct for a ...